Gufic Biosciences · NSE: GUFICBIO · BSE: 509079
Q1 FY19 results · Apr–Jun 2018
Gufic Biosciences reported revenue from operations of ₹78.49 crore and net profit of ₹3.93 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 78.49 | — | — | — | — |
| Other income | 0.22 | — | — | — | — |
| Total income | 78.72 | — | — | — | — |
| Profit before tax | 6.52 | — | — | — | — |
| Net profit for the period | 3.93 | — | — | — | — |
| EPS, basic (₹) | 0.51 | — | — | — | — |
| Net margin (%) | 5.0 | — | — |
Standalone
- Filed with BSE
- 18 Aug 2018, 12:20 IST
- Board meeting
- 13 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE